Market Overview, Growth of Toiletries Products, Cosmetic Sector Outlook, Cosmetic Products like Talcum Powder and Color Cosmetics, Market Overview and Growth of Toiletries Products

Annual Turnover: Rs.269 billion; Growth 6.4%
Exports: Rs.167 billion – Over 65 countries
Imports: Rs.44 billion; Growth 10.2%
Bulk Drugs Production: Rs.94 billion. Over 400 Bulk drugs manufactured
Future Market Size: 2010 – US$25 billion
Outsourcing Opportunities: Excellent outsourcing opportunities for clinical trials, R&D, custom synthesis, technical services, e.g. Bioinformatics, etc.
Manufacturing Facilities: Largest number of US FDA approved manufacturing facilities outside US
No. of DMFs (Drug Master Files) filed with US FDA: 197, largest DMF filed in US
Per Capita Drug Expenditure: Rs.250 per year
Share of World Pharma Market: 1.8% in value, 8% in volume terms
Global Ranking: Volume terms – 4th, Value terms – 14th
Number of Formulations: Over 60,000 in 60 therapeutic categories
Capital Investment: Rs.52 billion; Growth 14.8%
R&D Expenditure: Rs.11.8 billion, 4% of sales (However, some research based companies are spending over 6% of sales on R&D)
Ancillary Industry: Extremely well developed. All manufacturing equipment and machineries locally available
Number of Units: About 10,000, out of which around 300 units are in the large and medium sectors
Intellectual Capital: Third largest English speaking scientific and technical manpower in the world (highest intellectual capital per dollar)
Employment: Direct – 5,00,000; Indirect – 24,00,000
Price Control: 3 tier control – on Bulk Drugs, Formulations and Overall Profitability. Currently, 74 drugs under price control (40% of retail market) – Pharmaceutical Policy 2002 is currently under judicial review in Supreme Court. If cleared, likely to reduce number of drugs under price control from 74 to about 25.
OTC Market: Approx. Rs. 42 billion, Growth 18-20%
Alternative Medicine: Herbal, Ayurvedic, etc. – about Rs.44 billion
Biotech Market: Total Biotech Market in India is estimated to be Rs.67 billion. About 60% of this market is accounted by Biopharmaceuticals.
Health Infrastructure: No. of Doctors – 6,25,130; No. of Nurses – 8,36,000; No. of Hospitals – 16,000; No. of Retail Chemists – 5,00,000; Medical Colleges – 171; Primary Health Centres – 1,64,000; Medical Reps. – 3,00,000
Top 10 Companies (based on retail sales):
1. Cipla
2. GlaxoSmithKline
3. Ranbaxy
4. Nicholas Piramal
5. Sun Pharma
6. Pfizer
7. Dr. Reddy’s
8. Zydus Cadila
9. Sanofi-Aventis
10. Aristo
Top 10 Brands (based on retail sales):
1. Corex (Chlorpheniramine Maleate, Codeine Phosphate)
2. Human Mixtard (Insulin)
3. Voveran (Diclofenac Sodium)
4. Becosules (Vitamin B Complex, Vitamin C)
5. Taxim (Cefotaxime)
6. Asthalin (Salbutamol)
7. Sporidex (Cephalexin)
8. Digene (Aluminium Hydroxide, Magnesium Hydroxide)
9. Betnesol (Betamethasone)
10. Althrocin (Erythromycin)
Fastest growing segments: Anti-diabetic, Cardiovascular, Central Nervous System